Publication | Closed Access

Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study

MedicineBiliary CancerCancer TreatmentPhase 218-Fluorodeoxyglucose PetOncologyRadiation OncologyClinical OutcomeCancer ResearchRadiologyHealth Sciences